🇺🇸 FDA
Patent

US 8513214

C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV

granted A61PA61P31/12A61P31/14

Quick answer

US patent 8513214 (C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV) held by The United States of America as represented by the Secretary of the Dept. of Health & Human Services expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Dept. of Health & Human Services
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P31/12, A61P31/14, A61P31/18